Publications by authors named "D L Visca"
The effect of benralizumab on inflammation in severe asthma: a real-life analysis.
Ther Adv Respir Dis
December 2024
Background: Benralizumab is a monoclonal antibody treatment for severe eosinophilic asthma (SEA). Few studies investigated its role in airway inflammation and its correlation with lung function.
Objectives: The aim of the present study is to assess its effect after 1 year of treatment, focusing on airway inflammation.
Introduction: Asthma is a chronic inflammatory respiratory disease often associated with comorbidities. Among cardiovascular comorbidities, arterial hypertension seems to create an additional health burden in asthmatics. However, evidence on this relationship is lacking.
View Article and Find Full Text PDFArticle Synopsis
- - Mycobacterium chimaera is a non-tuberculous mycobacterium within the Mycobacterium avium complex (MAC) and is linked to infections after cardiac surgery due to heater-cooler units.
- - Although it is considered less virulent than other MAC species like M. avium and M. intracellulare, M. chimaera has been reported to cause lung infections, especially in patients with chronic conditions.
- - The text presents a specific case from Italy involving a patient with newly diagnosed chronic obstructive pulmonary disease (COPD) who contracted an infection from M. chimaera.